Research Article

Tuberculosis Treatment Outcomes and Factors Associated with Each of Them in a Cohort Followed Up between 2010 and 2014

Table 2

Clinical forms of tuberculosis and comorbidities by outcome of patients with tuberculosis treated at INI from 2012 to 2014.

VariablesCureTreatment failureDefaultDeadTotal

Total22214403279
Arterial hypertension
No187 (80)8 (03)37 (16)3 (01)235 (100)
Yes32 (80)6 (15)2 (05)0 (00)40 (100)
Diabetes
No198 (79)14 (06)37 (15)3 (01)252 (100)
Yes20 (87)0 (00)3 (13)0 (00)23 (100)
COPD
No216 (79)14 (5)40 (15)3 (1)273 (100)
Yes2 (100)0 (0)0 (0)0 (0)2 (100)
Hepatitis B
No217 (79)14 (5)40 (15)3 (1)274 (100)
Yes2 (100)0 (0)0 (0)0 (0)2 (100)
Hepatitis C
No218 (79)13 (5)40 (15)3 (1)274 (100)
Yes1 (50)1 (50)0 (0)0 (0)2 (100)
HIV
No171 (85)10 (5)21 (10)0 (0)202 (100)
Yes, without ARV19 (66)2 (7)7 (24)1 (3)29 (100)
Yes, with ARV28 (72)2 (5)7 (18)2 (5)39 (100)
Clinical form
Disseminated30 (73)3 (7)7 (17)1 (3)41 (100)
Extrapulmonary78 (87)5 (5)6 (7)1 (1)90 (100)
Pleuropulmonary114 (77)6 (4)27 (18)1 (1)148 (100)
Smear diagnosis
Negative106 (85)7 (6)11 (9)0 (0)124 (100)
Positive96 (72)7 (5)27 (20)3 (2)133 (100)
Positive MTB culture diagnosis
No86 (81)10 (9)10 (9)0 (0)106 (100)
Yes122 (78)4 (2)28 (18)3 (2)157 (100)

Chronic obstructive pulmonary disease; antiretroviral; Mycobacterium tuberculosis.